Product Information

MYCOPHENOLIC ACID DR 180 MG TB is a generic product labeled by Slate Run Pharmaceuticals LLC, priced at $0.1175 per EA under NDC 70436017223. Its NADAC has been published 242 times since Oct 6, 2021.

FDA first approved this application on Feb 10, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Mycophenolic Acid market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for MYCOPHENOLIC ACID DR 180 MG TB has been published 242 times since Oct 6, 2021, and over the history we have for it it has declined 86.5%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.